Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation-Reference-Cited by-同舟云学术

Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation

Published:2016-12-22 Issue:25 Volume:128 Page:3000-3010
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Aljitawi Omar S.¹²³⁴^ORCID,Paul Soumen³^ORCID,Ganguly Avishek³,Lin Tara L.¹²^ORCID,Ganguly Sid¹,Vielhauer George⁵,Capitano Maegan L.⁶,Cantilena Amy⁷,Lipe Brea¹²⁴,Mahnken Jonathan D.⁸,Wise Amanda¹²,Berry Abigale¹²,Singh Anurag K.¹^ORCID,Shune Leyla¹,Lominska Christopher⁹,Abhyankar Sunil¹,Allin Dennis¹⁰,Laughlin Mary¹¹¹²,McGuirk Joseph P.¹,Broxmeyer Hal E.⁶

Affiliation:

1. Division of Hematologic Malignancies and Cellular Therapy,

2. Hematology & Transplantation Translational Research Laboratory, and

3. Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS;

4. Division of Hematology/Oncology and Bone Marrow Transplantation Program, University of Rochester Medical Center, Rochester, NY;

5. Department of Urology, University of Kansas Medical Center, Kansas City, KS;

6. Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN;

7. Cardiovascular Research Institute,

8. Department of Biostatistics,

9. Department of Radiation Oncology, and

10. Department of Emergency Medicine, University of Kansas Medical Center, Kansas City, KS;

11. Cleveland Cord Blood Center, Cleveland, OH; and

12. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH

Abstract

Key Points EPO-EPOR signaling reduces UCB CD34+ HSPC engraftment through inhibition of BM homing and enhancement of erythroid differentiation. When used in clinical UCB transplantation, HBO therapy is safe and reduces EPO serum levels, potentially improving blood count recovery.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/128/25/3000/1397392/blood715292.pdf

Reference22 articles.

1. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities;Barker;Biol Blood Marrow Transplant,2010

2. Umbilical cord blood transplantation: the first 25 years and beyond;Ballen;Blood,2013

3. Cord Blood Hematopoietic Cell Transplantation;Broxmeyer,2016

4. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity;Migliaccio;Blood,2000

5. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow;Xia;Blood,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing;Molecular Therapy;2024-06

2. Umbilical Cord Blood Transplantation;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. An overview of hyperbaric oxygen preconditioning against ischemic stroke;Metabolic Brain Disease;2023-02-02

4. Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future;Stem Cells Translational Medicine;2023-02-01

5. Case Report: Unique patterns of lymphocyte recovery post-hematopoietic stem cell transplant associated with hyperbaric oxygen therapy: A case series;Frontiers in Hematology;2022-10-10